Given the above, and based on our previous work regarding the role of several molecules related to endothelial dysfunction, atherosclerosis, and disease severity in patients with chronic inflammatory disorders, Ang-2 among others [6], we aimed to investigate whether there could be differences in serum ANGPTL2 levels in HS patients compared with healthy controls. The gene discussed is ANGPTL2; the disease is atherosclerosis.